Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Benjamin A. H. Smith
Observed names:
Benjamin A.H. Smith,
Benjamin Smith
Observed institutions:
University of Freiburg,
University of California, Los Angeles,
Vanderbilt University,
University Medical Center Freiburg,
Vollum Institute,
Stanford Medicine,
Stanford University
show all 7
ORCID:
0000-0001-8802-416X
Observed ORCID:
0000-0001-8802-416X
OpenAlex ID:
A5101953791
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021
·
Ryan A. Flynn
, Kayvon Pedram
, et al.
·
Cell
·
644
PDF
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021
·
Benjamin A. H. Smith
, Carolyn R. Bertozzi
·
Nature Reviews Drug Discovery
·
502
PDF
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019
·
John V. Pluvinage
, Michael S. Haney
, et al.
·
Nature
·
458
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
2022
·
Johanna Theruvath
, Marie Menard
, et al.
·
Nature Medicine
·
254
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021
·
Simon Wisnovsky
, Leonhard Möckl
, et al.
·
Proceedings of the National Academy of Sciences
·
152
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1
2022
·
Nathaniel W. Mabe
, Min Huang
, et al.
·
Nature Cancer
·
122
PDF
MicroRNA-155–deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation
2015
·
Sophia Chen
, Benjamin A. H. Smith
, et al.
·
Blood
·
107
PDF
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019
·
C. Kimberly Tsui
, Robyn M. Barfield
, et al.
·
Nature Chemical Biology
·
85
Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD
2014
·
Anne-Kathrin Hechinger
, Benjamin A. H. Smith
, et al.
·
Blood
·
74
PDF
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
2023
·
Benjamin A. H. Smith
, Anja Deutzmann
, et al.
·
Proceedings of the National Academy of Sciences
·
72
Mammalian Y RNAs are modified at discrete guanosine residues with N-glycans
2019
·
Ryan A. Flynn
, Benjamin A. H. Smith
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
14
PDF
Author Correction: The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021
·
Benjamin A. H. Smith
, Carolyn R. Bertozzi
·
Nature Reviews Drug Discovery
·
11
PDF
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2025
·
Ryan A. Flynn
, Kayvon Pedram
, et al.
·
Cell
·
6
PDF
Trogocytosis targeting chimeras (TrogoTACs) for targeted protein transfer
2024
·
Nicholas A. Till
, Mirat Sojitra
, et al.
·
ChemRxiv
·
3
Anti-GD2 antibody disrupts GD2:Siglec-7 interactions and synergizes with CD47 blockade to mediate tumor eradication
2021
·
Johanna Theruvath
, Marie Menard
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
3
Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease
2023
·
Ellen R. Bowen
, Phillip DiGiacomo
, et al.
·
Discover Mental Health
·
2
PDF
Systematic identification of regulators of antibody-drug conjugate toxicity using CRISPR-Cas9 screens
2019
·
C. Kimberly Tsui
, Robyn M. Barfield
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease
2022
·
Jennifer Wilson
, Ellen Bowen
, et al.
·
Research Square
·
1
PDF
Abstract PR003: Lineage plasticity dictates responsiveness to anti-GD2 therapy in neuroblastoma
2022
·
Nathaniel W. Mabe
, Min Huang
, et al.
·
Cancer Research
Show more works
View as search
Works count:
20
Citation count:
2,512
H-index:
11
I10-index:
12
Year
Topic
Type
